Summary practice points
- As clinicians we must be familiar with alternative therapies, to help inform and guide women as to which options are most likely to be beneficial to them.
- Few complementary and alternative treatment options have proven evidence of effectiveness, but although many options do not stand up to scrutiny from a robust and evidence-based perspective there will be individual women who will benefit from some of these treatments.
- Placebo effect is not inconsiderable and in menopausal studies will play a part in individual experience and reported benefits.
This BMS Consensus Statement has been developed by the medical advisory council of the British Menopause Society
Reviewed: November 2025
Amended: July 2026 (to update Fezolinetant and add Elinzanetant)